Application of hexarelin to preparing kidney ischemia reperfusion injury protecting drugs/drug combinations
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE AFFILIATED HOSPITAL OF QINGDAO UNIV
- Publication Date
- 2019-06-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine, and in particular relates to the application of hexarelin in the preparation of a drug / medicine composition for protecting the kidney from ischemia-reperfusion injury. Background technique
[0002] Acute Kidney Injury (AKI) refers to a series of clinical syndromes caused by a sudden (within 1-7d) and continuous (>24h) decline in glomerular filtration function due to various reasons, and it is common in renal artery embolism , kidney transplantation, severe renal vascular disease, shock, acute heart failure, etc. Studies have shown that renal proximal tubular epithelial cells are the most seriously affected part of renal ischemia-reperfusion injury, mainly manifested as renal tubular atrophy and disappearance, proximal tubular epithelial cells apoptosis, necrosis, shedding, and capillary around renal tubules reduce. Since there is still a lack of effective diagnostic and therapeutic means to block ...